First COVID-19 convalescent plasma trial patient in SC fully recovers: Greenville Journal (SC)

Hardin wasn’t eligible for two clinical trials for COVID-19, but Ahuja told Hardin of the blood plasma trial that would transfer antibodies found in the plasma of someone who had recovered from COVID-19 — known as convalescent plasma — to her. Those antibodies from the donor would in turn help Hardin’s immune system fight off the virus.